Microbot Medical Inc (MBOT)

$3.07 -0.10 (-3.15%)
Market Cap 167.36M
Revenue (ttm) 0.00
Net Income (ttm) -11.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,509,000
Avg Vol 4,738,616
Day's Range N/A - N/A
Shares Out 52.80M
Stochastic %K 12%
Beta 1.25
Analysts Sell
Price Target $12.00

Company Profile

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides No...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 781-875-3605
Address:
175 Derby Street, Bld. 27, Hingham, United States
Graspoint
Graspoint Oct. 4 at 10:55 PM
$MBOT latest advances of the control, maneuvering and robotic tip functions are not revealed anymore in detail in contrast to some videos 5 years ago, since it is their unique IP. It just shows me how fierce the competition is, with many grudgers and copycats.
0 · Reply
sldprt
sldprt Oct. 4 at 9:37 PM
$MBOT instead of stupid bear, read this bull.
0 · Reply
grutpeter
grutpeter Oct. 4 at 7:29 PM
$MBOT on 10/04/2017 this was $20.55 a share. Anyone still here from back then. Hope not.
1 · Reply
The_Leprechaun
The_Leprechaun Oct. 4 at 5:01 PM
$MBOT
1 · Reply
Djmorri
Djmorri Oct. 4 at 10:28 AM
$MBOT . All that hype about FDA approval and this stock can not hold 4$. I loaded way too much on hopes of 5$ plus. We must now wait for bigger news…Profits…gonna be a looong wait… Admittedly, I’m tempted to take my profits and run
6 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 9:18 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $MBOT Current Share Price: $3.07 Contracts: $MBOT January 15, 2027 $5 Calls Scale in: $0.75- $0.91 Scale out: $1.16-$1.49 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
sldprt
sldprt Oct. 4 at 3:42 AM
$MBOT
0 · Reply
Djmorri
Djmorri Oct. 3 at 9:27 PM
$MBOT .Added
2 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Oct. 3 at 8:55 PM
$MBOT I’ll take some here around 3.00
1 · Reply
PlayingPossum
PlayingPossum Oct. 3 at 7:17 PM
$MBOT Each patent gives us 20 years exclusivity in that country. We have a great start with 13 issued. Some of those are in the biggest countries in the world. Bring on the sales, let’s go!!!
3 · Reply
Latest News on MBOT
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Oct 1, 2025, 9:00 AM EDT - 3 days ago

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Sep 23, 2025, 8:30 AM EDT - 11 days ago

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Sep 16, 2025, 3:37 PM EDT - 18 days ago

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

Sep 15, 2025, 8:00 AM EDT - 19 days ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Sep 9, 2025, 8:28 AM EDT - 25 days ago

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Sep 8, 2025, 8:28 AM EDT - 26 days ago

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Aug 28, 2025, 3:57 PM EDT - 5 weeks ago

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aug 20, 2025, 8:30 AM EDT - 6 weeks ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Aug 5, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 22, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jul 8, 2025, 8:30 AM EDT - 3 months ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Microbot Medical® Added to the Russell Microcap® Index

Jun 30, 2025, 8:30 AM EDT - 3 months ago

Microbot Medical® Added to the Russell Microcap® Index

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 17, 2025, 8:30 AM EDT - 3 months ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 9, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Jun 5, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 23, 2025, 8:30 AM EDT - 5 months ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 9, 2025, 8:30 AM EDT - 6 months ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Apr 1, 2025, 8:30 AM EDT - 6 months ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Mar 4, 2025, 8:30 AM EST - 7 months ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 25, 2025, 8:30 AM EST - 7 months ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 11, 2025, 6:15 PM EST - 8 months ago

Microbot Medical Closes $13 Million Registered Direct Offering

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Feb 10, 2025, 8:00 AM EST - 8 months ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 10, 2025, 10:25 AM EST - 9 months ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Jan 7, 2025, 4:15 PM EST - 9 months ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 30, 2024, 8:30 AM EST - 9 months ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Dec 10, 2024, 10:18 AM EST - 10 months ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Oct 15, 2024, 8:38 AM EDT - 1 year ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Jul 9, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Jul 8, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Jul 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Jun 20, 2024, 8:25 AM EDT - 1 year ago

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Jun 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 4, 2024, 4:20 PM EDT - 1 year ago

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 3, 2024, 12:11 PM EDT - 1 year ago

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Jun 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Apr 29, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Microbot Medical Shares Status Following Recent Geopolitical Events

Apr 15, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Shares Status Following Recent Geopolitical Events

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Feb 5, 2024, 7:30 AM EST - 1 year ago

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Jan 30, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Jan 18, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Dec 29, 2023, 8:00 AM EST - 1 year ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

Dec 28, 2023, 7:30 AM EST - 1 year ago

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

Dec 14, 2023, 8:15 AM EST - 1 year ago

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

Dec 7, 2023, 8:00 AM EST - 1 year ago

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

Graspoint
Graspoint Oct. 4 at 10:55 PM
$MBOT latest advances of the control, maneuvering and robotic tip functions are not revealed anymore in detail in contrast to some videos 5 years ago, since it is their unique IP. It just shows me how fierce the competition is, with many grudgers and copycats.
0 · Reply
sldprt
sldprt Oct. 4 at 9:37 PM
$MBOT instead of stupid bear, read this bull.
0 · Reply
grutpeter
grutpeter Oct. 4 at 7:29 PM
$MBOT on 10/04/2017 this was $20.55 a share. Anyone still here from back then. Hope not.
1 · Reply
The_Leprechaun
The_Leprechaun Oct. 4 at 5:01 PM
$MBOT
1 · Reply
Djmorri
Djmorri Oct. 4 at 10:28 AM
$MBOT . All that hype about FDA approval and this stock can not hold 4$. I loaded way too much on hopes of 5$ plus. We must now wait for bigger news…Profits…gonna be a looong wait… Admittedly, I’m tempted to take my profits and run
6 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 9:18 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $MBOT Current Share Price: $3.07 Contracts: $MBOT January 15, 2027 $5 Calls Scale in: $0.75- $0.91 Scale out: $1.16-$1.49 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
sldprt
sldprt Oct. 4 at 3:42 AM
$MBOT
0 · Reply
Djmorri
Djmorri Oct. 3 at 9:27 PM
$MBOT .Added
2 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Oct. 3 at 8:55 PM
$MBOT I’ll take some here around 3.00
1 · Reply
PlayingPossum
PlayingPossum Oct. 3 at 7:17 PM
$MBOT Each patent gives us 20 years exclusivity in that country. We have a great start with 13 issued. Some of those are in the biggest countries in the world. Bring on the sales, let’s go!!!
3 · Reply
Daquanladariusblackman2
Daquanladariusblackman2 Oct. 3 at 6:54 PM
$MBOT also stop putting words in peoples mouth I never said that either, I said you’re spreading lies and misinformation in an attempt to persuade people to sell. Why else would you come to a board where you have no skin in the game and blatantly lie. The things you’ve said aren’t even half truths or believable by anyone who’s done their research on the company. You are just outright lying, which is a violation of the rules and regulations here.
1 · Reply
Prash83
Prash83 Oct. 3 at 6:50 PM
$MBOT some retailers are just don’t have patience hence they always in loss 😀😀
0 · Reply
StockUpndDown
StockUpndDown Oct. 3 at 6:38 PM
$MBOT I got all my hope on this. I'm still surprised it didn't go up to and stay above $5 after the FDA approval
2 · Reply
Reddyrob
Reddyrob Oct. 3 at 6:21 PM
$MBOT Added yesterday around 3.08. It seems like $2.5 also possible. If then, i will be putting all my savings into this.
0 · Reply
ImCrazy
ImCrazy Oct. 3 at 5:57 PM
$MBOT Hope you did not sell!
1 · Reply
The_Leprechaun
The_Leprechaun Oct. 3 at 5:52 PM
$MBOT Take more of my money
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 5:50 PM
$MBOT: Unusual Options Activity Alerted CALL flow observed 500x contracts at Strike price of $2.5 Exp on 01/16/2026 with Premium of $50K and showing BULLISH Sentiment
1 · Reply
Trademate24
Trademate24 Oct. 3 at 5:41 PM
$MBOT
0 · Reply
blirp
blirp Oct. 3 at 5:13 PM
$MBOT Some days are..... Happy Friday everyone!!
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 4:49 PM
$LWLG $QLGN $MBOT $STRC Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
Barok
Barok Oct. 3 at 4:35 PM
$MBOT $ARBE $KITT $SERV How long before the rest of the bots wake up and follow $RR
0 · Reply
Daquanladariusblackman2
Daquanladariusblackman2 Oct. 3 at 3:28 PM
$MBOT every long on here should report @Eddypgil aka eddy the pig aka eddy the poor. He is intentionally trying to manipulate investors and persuade them to sell by spreading misinformation and FUD. He is investing with STXS and fears the liberty will steal their thunder. Do the world and our board a favor and get him banned
3 · Reply